Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
10.6M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
1.27M
-
Shares change
-
-722K
-
Total reported value, excl. options
-
$2.95M
-
Value change
-
-$3.47M
-
Put/Call ratio
-
54
-
Number of buys
-
11
-
Number of sells
-
-6
-
Price
-
$2.33
Significant Holders of Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) as of Q4 2021
24 filings reported holding ARDS - Aridis Pharmaceuticals, Inc. - Common Stock as of Q4 2021.
Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.27M shares
of 10.6M outstanding shares and own 11.95% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (507K shares), Roumell Asset Management, LLC (447K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (54.7K shares), BlackRock Inc. (43.2K shares), JANE STREET GROUP, LLC (39.7K shares), GEODE CAPITAL MANAGEMENT, LLC (38K shares), STATE STREET CORP (26.4K shares), PERRITT CAPITAL MANAGEMENT INC (24K shares), COMMONWEALTH EQUITY SERVICES, LLC (20.2K shares), and NORTHERN TRUST CORP (16.6K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.